Clinical trials and medical care: Defining the therapeutic misconception

PLoS Medicine

Volumn 4, Issue 11, 2007, Pages 1735-1738

  Henderson, Gail E ^a   Churchill, Larry R ^b   Davis, Arlene M ^a   Easter, Michele M ^a   Grady, Christine ^c   Joffe, Steven ^d   Kass, Nancy ^e   King, Nancy M P ^f   Lidz, Charles W ^g   Miller, Franklin G ^c   Nelson, Daniel K ^a   Peppercorn, Jeffrey ^a   Rothschild, Barbra Bluestone ^a   Sankar, Pamela ^h   Wilfond, Benjamin S ⁱ   Zimmer, Catherine R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d HARVARD UNIVERSITY   (United States)

^e Hopkins University   (United States)

^f WAKE FOREST UNIVERSITY   (United States)

^g UNIVERSITY OF MASSACHUSETTS   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEALTH SURVEY; HUMAN; INFORMED CONSENT; MEDICAL CARE; MEDICAL ETHICS; MEDICAL RESEARCH; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; STRUCTURED QUESTIONNAIRE; ARTICLE; BENEFICENCE; CLINICAL TRIAL (TOPIC); COGNITION; DECISION MAKING; HUMAN EXPERIMENT; INTERPERSONAL COMMUNICATION; MOTIVATION; PATIENT CARE; PATIENT PARTICIPATION; PATIENT SATISFACTION; RESEARCH; STANDARD;

BENEFICENCE; CLINICAL TRIALS AS TOPIC; COGNITION; DECISION MAKING; DISCLOSURE; GOALS; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; PATIENT CARE; PATIENT PARTICIPATION; PATIENT SATISFACTION; RESEARCH;

EID: 36849069884     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040324     Document Type: Review

References (44)

1. Levine RJ (1976) Boundaries between research involving human subjects and accepted and routine professional practices. In: Bogomolny RL, editor. Human experimentation. Dallas: Southern Methodist University Press. pp. 3-20.
2. Levine RJ (1978) The boundaries between biomedical or behavioral research and the accepted and routine practice of medicine. In: National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, editors. Appendix I, Belmont Report: Ethical principles and guidelines for the protection of human subjects of research. Washington (D. C.): National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
3. Appelbaum PS, Roth LH, Lidz C (1982) The therapeutic misconception: Informed consent in psychiatric research. Int J Law Psychiatry 5: 319-329.
4. Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W (1987) False hopes and best data: Consent to research and the therapeutic misconception. Hastings Cent Rep 17: 20-24.
5. National Bioethics Advisory Commission (2001) Ethical and policy issues in international research: Clinical trials in developing countries. Available: http://bioethics.georgetown.edu/nbac/pubs.html. Accessed 28 October 2007.
6. Lidz CW, Appelbaum PS (2002) The therapeutic misconception: problems and solutions. Med Care 40: V55-V63.
7. Joffe S, Weeks JC (2002) Views of American oncologists about the purposes of clinical trials. J Natl Cancer Inst 94: 1847-1853.
8. Kimmelman J, Levenstadt A (2005) Elements of style: Consent form language and the therapeutic misconception in phase 1 gene transfer trials. Hum Gene Ther 16: 502-508.
9. Brody BA, McCullough LB, Sharp RR (2005) Consensus and controversy in clinical research ethics. JAMA 294: 1411-1414.
10. Dresser R (2002) The ubiquity and utility of the therapeutic misconception. Soc Philos Policy 19: 271-294.
11. Henderson GE, Easter MM, Zimmer C, King NM, Davis AM, et al. (2006) Therapeutic misconception in early phase gene transfer trials. Soc Sci Med 62: 239-253.
12. Henderson GE, Davis AM, King NM, Easter MM, Zimmer CR, et al. (2004) Uncertain benefit: Investigators' views and communications in early phase gene transfer trials. Mol Ther 10: 225-231.
13. Henderson GE, Davis AM, King NM (2004) Vulnerability to influence: A two-way street. Am J Bioeth 4: 50-52; discussion W32.
14. Churchill LR, Nelson DK, Henderson GE, King NMP, Davis AM, et al. (2003) Assessing benefits in clinical research: Why diversity in benefit assessment can be risky. IRB 25: 1-8.
15. King NMP, Henderson GE, Churchill LR, Davis AM, Hull SC, et al. (2005) Consent forms and the therapeutic misconception: The example of gene transfer research. IRB 27: 1-8.
16. Davis AM, Hull SC, Grady C, Wilfond BS, Henderson GE (2002) The invisible hand in clinical research: The study coordinator's critical role in human subjects protection. J Law Med Ethics 30: 411-419.
17. Easter MM, Henderson GE, Davis AM, Churchill LR, King NM (2006) The many meanings of care in clinical research. Sociol Health Illn 28: 695-712.
18. DeVellis RM (2003) Scale development: Theory and applications. Thousand Oaks (CA): Sage Publications.
19. Appelbaum PS, Lidz CW, Grisso T (2004) Therapeutic misconception in clinical research: Frequency and risk factors. IRB 26: 1-8.
20. Lantos JD (1999) The "inclusion benefit" in clinical trials. J Pediatr 134: 130-131.
21. King NMP (2000) Defining and describing benefit appropriately in clinical trials. J Law Med Ethics 28: 332-343.
22. Joffe S, Miller FG (2006) Rethinking risk-benefit assessment for phase I cancer trials. J Clin Oncol 24: 2987-2990.
23. Levine RJ (1986) Ethics and regulation of clinical research. Baltimore: Urban & Schwarzenberg. 452 p.
24. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1979) Belmont Report: Ethical principles and guidelines for the protection of human subjects of research. Washington (D. C.): National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research.
25. Appelbaum PS, Lidz C (2006) Re-evaluating the therapeutic misconception: Response to Miller and Joffe. Kennedy Inst Ethics J 16: 367-373.
26. Miller FG, Joffe S (2006) Evaluating the therapeutic misconception. Kennedy Inst Ethics J 16: 353-366.
27. Lidz CW, Appelbaum PS, Grisso T, Renaud M (2004) Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med 58: 1689-1697.
28. King NMP (1999) Rewriting the "points to consider": The ethical impact of guidance document language. Hum Gene Ther 10: 133-139.
29. Weinfurt KP, Castel LD, Li Y, Sulmasy DP, Balshem AM, et al. (2003) The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer 98: 166-175.
30. Arkin LM, Sondhi D, Worgall S, Suh LH, Hackett NR, et al. (2005) Confronting the issues of therapeutic misconception, enrollment decisions, and personal motives in genetic medicine-based clinical research studies for fatal disorders. Hum Gene Ther 16: 1028-1036.
31. Daugherty CK, Banik DM, Janish L, Ratain MJ (2000) Quantitative analysis of ethical issues in phase I trials: A survey interview of 144 advanced cancer patients. IRB 22: 6-14.
32. Horng S, Grady C (2003) Misunderstanding in clinical research: Distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. IRB 25: 11-16.
33. Dunn LB, Palmer BW, Keehan M, Jeste DV, Appelbaum PS (2006) Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument. Am J Psychiatry 163: 500-506.
34. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC (2001) Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet 358: 1772-1777.
35. Schaeffer MH, Krantz DS, Wichman A, Masur H, Reed E, et al. (1996) The impact of disease severity on the informed consent process in clinical research. Am J Med 100: 261-268.
36. Kass NE, Sugarman J, Faden R, Schoch-Spana M (1996) Trust, The fragile foundation of contemporary biomedical research. Hastings Cent Rep 26: 25-29.
37. Sugarman J, Lavori PW, Boeger M, Cain C, Edsond R, et al. (2005) Evaluating the quality of informed consent. Clin Trials 2: 34-41.
38. Advisory Committee on Human Radiation Experiments (1995) Final report of the advisory committee on human radiation experiments. Washington (D. C.): US Government Publishing Office.
39. Sankar P (2004) Communication and miscommunication in informed consent to research. Med Anthropol Q 18: 429-446.
40. Miller M (2000) Phase I cancer trials. A collusion of misunderstanding. Hastings Cent Rep 30: 34-43.
41. Vist GE, Hagen KB, Devereaux PJ, Bryant D, Kristoffersen DT, et al. (2005) Systematic review to determine whether participation in a trial influences outcome. BMJ 330: 1175.
42. Peppercorn JM, Weeks JC, Cook EF, Joffe S (2004) Comparison of outcomes in cancer patients treated within and outside clinical trials: Conceptual framework and structured review. Lancet 363: 263-270.
43. Braunholtz DA, Edwards SJ, Lilford RJ (2001) Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect." J Clin Epidemiol 54: 217-224.
44. Miller FG, Brody H (2003) A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Hastings Cent Rep 33: 19-28.